Age-relatedmedication adherence in patients with chronic heart failure: A systematic literature review

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 728-735

  Krueger, Katrin ^a   Botermann, Lea ^a   Schorr, Susanne G ^b   Griese Mammen, Nina ^a   Laufs, Ulrich ^c   Schulz, Martin ^a,d  

^a ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

^b Agency for Quality in Medicine   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Age; Chronic heart failure; Elderly; Medication adherence; Systematic literature review

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; CARDIOVASCULAR AGENT;

AGE; ARTICLE; DRUG EFFICACY; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MEDICATION COMPLIANCE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SYSTEMATIC REVIEW; CHRONIC DISEASE; PSYCHOLOGY;

AGE FACTORS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; HEART FAILURE; HUMANS; MEDICATION ADHERENCE;

EID: 84933564213     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.042     Document Type: Article

References (84)

1. W.B. Kannel, Incidence and epidemiology of heart failure, Heart Fail. Rev. 5 (2000) 167-173.
2. J.G. Cleland, K. Swedberg, F. Follath, M. Komajda, A. Cohen-Solal, J.C. Aguilar, R. Dietz, et al., The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis, Eur. Heart J. 24 (2003) 442-463.
3. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, et al., ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association (HFA) of the ESC, Eur. Heart J. 33 (2012) 1787-1847.
4. E. Sabaté, Adherence to Long-termTherapies: Evidence for Action, World Health Organization, Geneva, 2003.
5. B.B. Granger, K. Swedberg, I. Ekman, C.B. Granger, B. Olofsson, J.J. McMurray, S. Yusuf, et al., Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial, Lancet 366 (2005) 2005-2011.
6. B. Riegel, G.J. Knafl, Electronically monitored medication adherence predicts hospitalization in heart failure patients, Patient Prefer. Adherence 8 (2013) 1-13.
7. P. Muntner, J.H. Halanych, K. Reynolds, R. Durant, S. Vupputuri, V.W. Sung, J.F. Meschia, et al., Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study, J. Clin. Hypertens. 13 (2011) 479-486.
8. J. Wu, T.A. Lennie, R.L. Dekker, M.J. Biddle, D.K. Moser, Medication adherence, depressive symptoms, and cardiac event-free survival in patients with heart failure, J. Card. Fail. 19 (2013) 317-324.
9. A.A. Fitzgerald, J.D. Powers, P.M. Ho, T.M. Maddox, P.N. Peterson, L.A. Allen, F.A. Masoudi, et al., Impact of medication nonadherence on hospitalizations and mortality in heart failure, J. Card. Fail. 17 (2011) 664-669.
10. P.S. Corotto, M.M. McCarey, S. Adams, P. Khazanie, D.J. Whellan, Heart failure patient adherence: epidemiology, cause, and treatment, Heart Fail. Clin. 9 (2013) 49-58.
11. M.L. Alosco, M.B. Spitznagel, M. van Dulmen, N. Raz, R. Cohen, L.H. Sweet, L.H. Colbert, et al., Cognitive function and treatment adherence in older adults with heart failure, Psychosom. Med. 74 (2012) 965-973.
12. D.K. Moser, P.L. Worster, Effect of psychosocial factors on physiologic outcomes in patients with heart failure, J. Cardiovasc. Nurs. 14 (2000) 106-115.
13. R.D. Schweitzer, K. Head, J.W. Dwyer, Psychological factors and treatment adherence behaviour in patients with chronic heart failure, J. Cardiovasc. Nurs. 22 (2007) 76-83.
14. A. Skalska, B. Wizner, A. Więcek, T. Zdrojewski, J. Chudek, A. Klich-Rączka, K. Piotrowicz, et al., Reduced functionality in everyday activities of patients with self-reported heart failure hospitalization-population-based study results, Int. J. Cardiol. 176 (2014) 423-429.
15. R.B. Haynes (Ed.), Compliance in Health Care, Johns Hopkins Univ. Press, Baltimore, 1979.
16. L. Lorenc, A. Branthwaite, Are older adults less compliant with prescribed medication than younger adults? Br. J. Clin. Psychol. 32 (Pt 4) (1993) 485-492.
17. M. Monane, R.L. Bohn, J.H. Gurwitz, R.J. Glynn, R. Levin, J. Avorn, Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race, Am. J. Public Health 86 (1996) 1805-1808.
18. M.R. Cowie, A. Mosterd, D.A. Wood, J.W. Deckers, P.A. Poole-Wilson, G.C. Sutton, D.E. Grobbee, The epidemiology of heart failure, Eur. Heart J. 18 (1997) 208-225.
19. M.H.L. van der Wal, T. Jaarsma, Adherence in heart failure in the elderly: problem and possible solutions, Int. J. Cardiol. 125 (2008) 203-208.
20. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, Preferred reporting items for systematic reviews andmeta-analyses: the PRISMA statement, Int. J. Surg. 8 (2010) 336-341.
21. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, J.P. Ioannidis, M. Clarke, et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med. 6 (2009) e1000100.
22. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
23. J.A. Hayden, P. Côté, C. Bombardier, Evaluation of the quality of prognosis studies in systematic reviews, Ann. Intern. Med. 144 (2006) 427-437.
24. R. Oosterom-Calo, A.J. van Ballegooijen, C.B. Terwee, S.J. te Velde, I.A. Brouwer, T. Jaarsma, J. Brug, Determinants of adherence to heart failuremedication: a systematic literature review, Heart Fail. Rev. 18 (2013) 409-427.
25. R.E. Slavin, Best evidence synthesis: an intelligent alternative to meta-analysis, J. Clin. Epidemiol. 48 (1995) 9-18.
26. J. Roebuck, When does "old age begin?": the evolution of the English definition, J. Soc. Hist. 12 (1979) 416-428.
27. D. Ogilvie, D. Fayter, M. Petticrew, A. Sowden, S. Thomas, M. Whitehead, G. Worthy, The harvest plot: a method for synthesising evidence about the differential effects of interventions, BMC Med. Res. Methodol. 8 (2008) 8.
28. J. Wu, D.K. Moser, T.A. Lennie, P.V. Burkhart, Medication adherence in patients who have heart failure: a review of the literature, Nurs. Clin. North Am. 43 (2008) 133-153.
29. C. Kongkaew, I. Sakunrag, P. Jianmongkol, Non-compliance with digoxin in patients with heart failure and/or atrial fibrillation: a systematic review andmeta-analysis of observational studies, Arch. Cardiovasc. Dis. 105 (2012) 507-516.
30. M.H.L. van derWal, T. Jaarsma, D.J. van Veldhuisen, Non-compliance in patients with heart failure; how can we manage it? Eur. J. Heart Fail. 7 (2005) 5-17.
31. A.D. Bagchi, D. Esposito, M. Kim, J. Verdier, D. Bencio, Utilization of, and adherence to, drug therapy among Medicaid beneficiaries with congestive heart failure, Clin. Ther. 29 (2007) 1771-1783.
32. L.S. Evangelista, J. Berg, K. Dracup, Relationship between psychosocial variables and compliance in patients with heart failure, Heart Lung 30 (2001) 294-301.
33. M. Monane, R.L. Bohn, J.H. Gurwitz, R.J. Glynn, J. Avorn, Noncompliancewith congestive heart failure therapy in the elderly, Arch. Intern. Med. 154 (1994) 433-437.
34. P.T. Rodgers, D.M. Ruffin, Medication nonadherence: part II-a pilot study in patients with congestive heart failure, Manag. Care Interface 11 (1998) 67-69 (75).
35. K. Yayehd, F. Damorou, M.P. N'cho Mottoh, T. Tchérou, A. Johnson, S. Pessinaba, Y. Tété, et al., Observance thérapeutique de l'insuffisant cardiaque à Lomé, Ann. Cardiol. Angeiol. (Paris) 62 (2013) 22-27.
36. M.W. Rich, D.B. Gray, V. Beckham, C. Wittenberg, P. Luther, Effect of amultidisciplinary intervention onmedication compliance in elderly patients with congestive heart failure, Am. J. Med. 101 (1996) 270-276.
37. S. Setoguchi, N.K. Choudhry, R. Levin, W.H. Shrank, W.C. Winkelmayer, Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure, Clin. Pharmacol. Ther. 88 (2010) 548-554.
38. J. Wu, D.K. Moser, M.L. Chung, T.A. Lennie, Predictors of medication adherence using a multidimensional adherence model in patients with heart failure, J. Card. Fail. 14 (2008) 603-614.
39. A.V. Ambardekar, G.C. Fonarow, A.F. Hernandez, W. Pan, C.W. Yancy, M.J. Krantz, Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF), Am. Heart J. 158 (2009) 644-652.
40. S.M. Dunlay, J.M. Eveleth, N.D. Shah, S.M. McNallan, V.L. Roger, Medication adherence among community-dwelling patients with heart failure, Mayo Clin. Proc. 86 (2011) 273-281.
41. B.B. Granger, I. Ekman, C.B. Granger, J. Ostergren, B. Olofsson, E. Michelson, J.J. McMurray, et al., Adherence to medication according to sex and age in the CHARM programme, Eur. J. Heart Fail. 11 (2009) 1092-1098.
42. A. Michalsen, G. König, W. Thimme, Preventable causative factors leading to hospital admission with decompensated heart failure, Heart 80 (1998) 437-441.
43. T. Miura, R. Kojima, Y. Sugiura, M. Mizutani, F. Takatsu, Incidence of noncompliance and its influencing factors in patients receiving digoxin, Clin. Drug lnvest. (2000) 123-130.
44. M. Mockler, C. O'Loughlin, N. Murphy, M. Ryder, C. Conlon, K.M. McDonald, M.T. Ledwidge, Causes and consequences of nonpersistence with heart failure medication, Am. J. Cardiol. 103 (2009) 834-838.
45. M. Modares-Mosadegh, S.M. Sadr Bafghi, Digoxin compliance: a pharmacokinetic quantification, Med. J. I.A.S. (2001) 117-122.
46. S. Muzzarelli, H. Brunner-La Rocca, O. Pfister, P. Foglia, G. Moschovitis, G. Mombelli, H. Stricker, Adherence to the medical regime in patients with heart failure, Eur. J. Heart Fail. 12 (2010) 389-396.
47. C.M. Wong, N.M. Hawkins, P.S. Jhund, M.R. MacDonald, S.D. Solomon, C.B. Granger, S. Yusuf, et al., Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity), J. Am. Coll. Cardiol. 62 (2013) 1845-1854.
48. L. Evangelista, L.V. Doering, K. Dracup, C. Westlake, M. Hamilton, G.C. Fonarow, Compliance behaviours of elderly patients with advanced heart failure, J. Cardiovasc. Nurs. 18 (2003) 197-206 (quiz 207-8).
49. N.T. Artinian, M. Magnan, M. Sloan, M.P. Lange, Self-care behaviours among patients with heart failure, Heart Lung 31 (2002) 161-172.
50. J.E. Bailey, M.D. Lee, G.W. Somes, R.L. Graham, Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care, Clin. Ther. 18 (1996) 1252-1262.
51. Gabrielle K.Y. Lee, Harry H.X. Wang, Kirin Q.L. Liu, Yu Cheung, Donald E. Morisky, Martin C.S. Wong, Determinants ofmedication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale, PLoS One 8 (2013) e62775.
52. P. Assawasuwannakit, R. Braund, S.B. Duffull, A model-based meta-analysis of the influence of factors that impact adherence to medications, J. Clin. Pharm. Ther. 40 (2015) 24-31.
53. E.A. Graveley, C.S. Oseasohn, Multiple drug regimens: medication compliance among veterans 65 years and older, Res. Nurs. Health 14 (1991) 51-58.
54. M.J. Cohen, S. Shaykevich, C. Cawthon, S. Kripalani, M.K. Paasche-Orlow, J.L. Schnipper, Predictors of medication adherence postdischarge: the impact of patient age, insurance status, and prior adherence, J. Hosp. Med. 7 (2012) 470-475.
55. M.A. Fischer, M.R. Stedman, J. Lii, C. Vogeli, W.H. Shrank, M.A. Brookhart, J.S. Weissman, Primary medication non-adherence: analysis of 195, 930 electronic prescriptions, J. Gen. Intern. Med. 25 (2010) 284-290.
56. R. Nieuwlaat, N. Wilczynski, T. Navarro, N. Hobson, R. Jeffery, A. Keepanasseril, T. Agoritsas, et al., Interventions for enhancing medication adherence, Cochrane Database Syst. Rev. 11 (2014) CD000011.
57. W.H. Shrank, T. Hoang, S.L. Ettner, P.A. Glassman, K. Nair, D. DeLapp, J. Dirstine, et al., The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions, Arch. Intern. Med. 166 (2006) 332-337.
58. T.H. Wroth, D.E. Pathman, Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care, J. Am. Board Fam. Med. 19 (2006) 478-486.
59. A. Ekedahl, N. Månsson, Unclaimed prescriptions after automated prescription transmittals to pharmacies, Pharm. World Sci. 26 (2004) 26-31.
60. L.H. Huang, Medication-taking behaviour of the elderly, Kaohsiung J. Med. Sci. 12 (1996) 423-433.
61. M.H.L. van der Wal, T. Jaarsma, D. Moser, N. Veeger, W.H. van Gilst, D.J. van Veldhuisen, Compliance in heart failure patients: the importance of knowledge and beliefs, Eur. Heart J. 27 (2006) 434-440.
62. D.M. Zulman, J.B. Sussman, X. Chen, C.T. Cigolle, C.S. Blaum, R.A. Hayward, Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials, J. Gen. Intern. Med. 26 (2011) 783-790.
63. M.E. McMurdo, M.D. Witham, N.D. Gillespie, Including older people in clinical research, BMJ 331 (2005) 1036-1037.
64. I.A. Scott, G.H. Guyatt, Cautionary tales in the interpretation of clinical studies involving older persons, Arch. Intern. Med. 170 (2010) 587-595.
65. F.A. Masoudi, E.P. Havranek, P. Wolfe, C.P. Gross, S.S. Rathore, J.F. Steiner, D.L. Ordin, et al., Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure, Am. Heart J. 146 (2003) 250-257.
66. S. Banerjee, Multimorbidity-older adults need health care that can count past one, Lancet 385 (2015) 587-589. PMID:25468155.
67. M.J. Leventhal, B. Riegel, B. Carlson, S. de Geest, Negotiating compliance in heart failure: remaining issues and questions, Eur. J. Cardiovasc. Nurs. 4 (2005) 298-307.
68. S.A. AlGhurair, C.A. Hughes, S.H. Simpson, L.M. Guirguis, A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model, J. Clin. Hypertens. (Greenwich) 14 (2012) 877-886.
69. A. Lehmann, P. Aslani, R. Ahmed, J. Celio, A. Gauchet, P. Bedouch, O. Bugnon, et al., Assessing medication adherence: options to consider, Int. J. Clin. Pharm. 36 (2014) 55-69.
70. D.E. Morisky, L.W. Green, D.M. Levine, Concurrent and predictive validity of a selfreported measure of medication adherence, Med. Care 24 (1986) 67-74.
71. L. Osterberg, T. Blaschke, Adherence to medication, N. Engl. J. Med. 353 (2005) 487-497.
72. R. Ahmed, P. Aslani, What is patient adherence? A terminology overview, Int. J. Clin. Pharm. 36 (2014) 4-7.
73. H. Smith, M. Hankins, A. Hodson, C. George, Measuring the adherence to medication of elderly patients with heart failure: is there a gold standard? Int. J. Cardiol. 145 (2010) 122-123.
74. M. Viswanathan, C.E. Golin, C.D. Jones, M. Ashok, S.J. Blalock, R.C. Wines, E.J. Coker- Schwimmer, et al., Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review, Ann. Intern. Med. 157 (2012) 785-795.
75. J. Wu, D.A. DeWalt, D.W. Baker, D. Schillinger, B. Ruo, K. Bibbins-Domingo, A. Macabasco-O'Connell, et al., A single-item self-report medication adherence question predicts hospitalisation and death in patients with heart failure, J. Clin. Nurs. 23 (2013) 2554-2564. PMID:24355060.
76. M. Egger, G.D. Smith, D.G. Altman, Systematic Reviews in Health Care:Meta-analysis in Context, 2nd ed. BMJ Books, London, 2001. (©).
77. K.S. Khan, Systematic Reviews to Support Evidence-basedMedicine: How to Review and Apply Findings of Healthcare Research, 2nd ed. Hodder Annold, London, 2011.
78. F.J. Mateen, J. Oh, A.I. Tergas, N.H. Bhayani, B.B. Kamdar, Titles versus titles and abstracts for initial screening of articles for systematic reviews, Clin. Epidemiol. 5 (2013) 89-95.
79. K.F. Schulz, I. Chalmers, R.J. Hayes, D.G. Altman, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA 273 (1995) 408-412.
80. L.L. Kjaergard, J. Villumsen, C. Gluud, Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses, Ann. Intern. Med. 135 (2001) 982-989.
81. R. Sikka, F. Xia, R.E. Aubert, Estimating medication persistency using administrative claims data, Am. J. Manage Care 11 (2005) 449-457.
82. G.A. Hilbert, Accuracy of self-reportedmeasures of compliance, Nurs. Res. 34 (1985) 319-320.
83. J.F. Steiner, T.D. Koepsell, S.D. Fihn, T.S. Inui, A general method of compliance assessment using centralized pharmacy records. Description and validation, Med. Care 26 (1988) 814-823.
84. X. Girerd, O. Hanon, K. Anagnostopoulos, C. Ciupek, J.J. Mourad, S. Consoli, Evaluation de l'observance du traitement antihypertenseur par un questionnaire:mise au point et utilisation dans un service spécialisé, Presse Med. (Paris) 30 (2001) 1044-1048.